- Case report
- Open Access
- Open Peer Review
Chondrosarcoma presenting as dyspnea in a 19-year-old man: a case report
© Chandrasekharan et al; licensee BioMed Central Ltd. 2011
- Received: 19 April 2010
- Accepted: 15 April 2011
- Published: 15 April 2011
Acute pulmonary embolism has varied presentations ranging from asymptomatic, incidentally discovered emboli to massive embolism, causing immediate death. Tumor embolism is a rare but unique complication of malignancies. This uncommon catastrophe of a malignant tumor in a young patient, culminating as a pulmonary embolism, is being reported for the first time.
A 19-year-old Asian man presented to the emergency service at our hospital with acute onset dyspnea. His clinical examination led to the suspicion of an acute pulmonary embolism with a lower lumbosacral radiculopathy. A magnetic resonance imaging scan of the pelvis demonstrated a chondrosarcoma arising from the right iliac wing, eroding into the common iliac vein and creeping up the inferior vena cava to lodge in the pulmonary artery, thus producing a saddle embolus.
The importance of exploring for malignancies in the event of an idiopathic pulmonary embolism is highlighted. Early detection of such malignancies can substantially affect the outcome in young patients.
- Pulmonary Embolism
- Main Pulmonary Artery
- Acute Pulmonary Embolism
- Tumor Embolism
Detached thrombi or tumour may be the cause for massive pulmonary embolism in patients with malignancies. Identification of the type of pulmonary embolism is cardinal as the treatment and prognosis vary considerably. We report an unusual presentation of a tumour embolism in a young man, who succumbed to the disease.
A 19-year-old Asian man, was admitted to the emergency services (ES) at our hospital with acute onset of severe breathlessness following a short duration of dry cough, without any associated fever, chest pain or hemoptysis. He also had lower-back pain and right lower limb weakness with paresthesia, which was attributed to an injury sustained while playing football. He was prescribed analgesics and advised by an orthopedic surgeon to take bed rest for his lower limb ailment. His lower-back radiograph was normal. On examination at the ES, he had tachypnea and tachycardia with elevated jugular venous pressure and was normotensive with no pallor or pedal edema. His cardiovascular system examination revealed a loud second heart sound and a right ventricular third heart sound. His respiratory system examination was normal. The examination of his nervous system was suggestive of a right lower lumbosacral (L3-S1) radiculopathy. A moderate, tender hepatomegaly was detected in abdominal palpation. His oxygen saturation in the ES was 92 percent at room air temperature.
Malignancy is one of the well-known risk factors for pulmonary embolism. Rarely, embolism of the tumor tissue itself or tumor cells can occlude the main pulmonary artery or its large branches, causing dyspnea. This is called tumor embolism and is exceedingly difficult to recognize before death. Autopsy series have estimated the incidence of pulmonary tumor embolism to be between 3% and 26% among patients with solid tumors [1, 2]. The majority of reported cases are in association with breast, stomach or lung carcinomas . Chondrosarcomas, the third most common primary malignancy of the bone, usually grow slowly and metastasize . In some cases, however, this course is altered dramatically by a long-recognized feature of this tumor: intravascular invasion.
Very few case reports have confirmed the association of tumor embolism and chondrosarcoma [5–7]. In the case reported here, a pelvic chondrosarcoma was responsible for the thrombus. The unusual feature of this tumor was its transvenous spread involving the pelvic and retroperitoneal veins all the way to the inferior vena cava (Figure 3) and causing subsequent tumor embolization. MRI and Doppler ultrasound scans together could detect the invasion. No report of a major case series of chondrosarcoma has discussed this complication.
A good proportion of patients with tumor embolisms already have widespread metastatic disease at the time of presentation. Hence, there is a paucity of prospective trials of chemotherapy in these patients. The treatment options available in such situations are surgical embolectomy and treatment of the primary tumor, which includes wide en bloc excision, radiotherapy, palliative care and antiangiogenesis combined with chemotherapy [4, 8]. Few cases of successful chemotherapy of tumor embolism have been described in the literature [9, 10]. The most important decision involving a patient suspected of having a tumor embolism is how aggressively to pursue the diagnosis. An early confirmation of the presence of tumor embolism may avoid unnecessary anticoagulation and thrombolytic therapy, which are absolute indications in cases of thromboembolism. There are also chances of complete remission of the tumor if adequate chemotherapy is initiated well in advance. The patient reported here showed symptomatic improvement after surgery. However, the tumor had already caused widespread damage. Hence, radiotherapy had to be initiated, followed by palliation.
Occurrence of an acute pulmonary embolism in a cancer patient should always prime the clinician to search for tumor thrombosis. The refractoriness of the thrombus to thrombolysis therapy, as in the reported case, is yet another pointer to tumor embolism. Whenever chondrosarcoma of the pelvis is suspected in a young patient, the possibility of extensive venous extension should be considered and appropriate diagnostic tests should be performed early to avoid unnecessary anticoagulation and initiate appropriate chemotherapy.
Written informed consent was obtained from the patient's father for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Shields DJ, Edwards WD: Pulmonary hypertension attributable to neoplastic emboli: an autopsy study of 20 cases and a review of the literature. Cardiovasc Pathol. 1992, 1: 279-287. 10.1016/1054-8807(92)90038-P.View ArticlePubMedGoogle Scholar
- Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Eds: Cancer Medicine. 2000, Hamilton, ON, Canada: B.C. Decker, 5Google Scholar
- Roberts KE, Hamele-Bena D, Saqi A, Stein CA, Cole RP: Pulmonary tumour embolism: a review of the literature. Am J Med. 2003, 15: 228-232. 10.1016/S0002-9343(03)00305-X.View ArticleGoogle Scholar
- Gelderblom H, Hogendoorn PCW, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AHM, Bovée JV: The clinical approach towards chondrosarcoma. Oncologist. 2008, 13: 320-329. 10.1634/theoncologist.2007-0237.View ArticlePubMedGoogle Scholar
- Hayashida K, Nishimura T, Uehara T, Naito H, Takamiya M, Kozuka T, Sakakibara H, Imakita M, Yutani C, Hamada T: [A case of pulmonary tumor-embolism from chondrosarcoma of the lower extremity] (in Japanese). Kaku Igaku. 1985, 22: 101-106.PubMedGoogle Scholar
- Leung DY, Seah PW, Lee LC, Cranney GB, Walsh WF: Embolic chondrosarcoma: an unusual cause of pulmonary embolism. Am Heart J. 1993, 126: 732-734. 10.1016/0002-8703(93)90434-B.View ArticlePubMedGoogle Scholar
- Yoshida K, Miyashita N, Nakajima M, Niki Y, Matsushima T: [A case of sternal chondrosarcoma with multiple pulmonary embolisms] (in Japanese). Nihon Kokyuki Gakkai Zasshi. 2002, 40: 166-170. 10.3753/yotsu.8.166.View ArticlePubMedGoogle Scholar
- Morioka H, Weissbach L, Vogel T, Nielsen GP, Faircloth GT, Shao L, Hornicek FJ: Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res. 2003, 9: 1211-1217.PubMedGoogle Scholar
- Kosugi M, Ono T, Yamaguchi H, Sato N, Dan K, Tanaka K, Takano T: Successful treatment of primary cardiac lymphoma and pulmonary tumor embolism with chemotherapy. Int J Cardiol. 2006, 111: 172-173. 10.1016/j.ijcard.2005.06.054.View ArticlePubMedGoogle Scholar
- Wong PS, Aye WMM, Lee CN: Pulmonary tumor embolism secondary to osteosarcoma. Ann Thorac Surg. 2004, 77: 341-10.1016/S0003-4975(03)00472-7.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.